Table 5.
Postoperative survival and TTF-1 expression and EGFR gene mutation status in different categories of patients
Category | TTF-1
|
EGFR
|
||
---|---|---|---|---|
χ2 | P-value | χ2 | P-value | |
Age | ||||
>61 years | 0.096 | 0.757 | 2.330 | 0.127 |
≤61 years | 3.729 | 0.053 | 0.763 | 0.382 |
Sex | ||||
Male | 0.381 | 0.537 | 1.062 | 0.303 |
Female | 0.281 | 0.596 | 2.134 | 0.144 |
Smoking | ||||
Ever | 0.068 | 0.795 | 2.011 | 0.156 |
Never | 1.224 | 0.269 | 0.427 | 0.514 |
Tumor location | ||||
Left | 0.000 | 0.999 | 2.889 | 0.089 |
Right | 1.562 | 0.211 | 0.487 | 0.485 |
Pathological stage | ||||
I–II | 0.889 | 0.346 | 1.638 | 0.201 |
III–IV | 4.578 | 0.032 | 2.075 | 0.150 |
Abbreviations: EGFR, epidermal growth factor receptor; TTF-1, thyroid transcription factor-1.